HB

The mark consists of the letters "hb" in lower case letters with the letter "h" at the top and the letter "b" on the bottom sharing the end of the letter "h" slant to form the "b" inside of a slanted shaded square.

Mark For: HB™ trademark registration is intended to cover the categories of intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS. [all]

>Color is not claimed as a feature of the mark. The mark consists of the letters "hb" in lower case letters with the letter "h" at the top and the letter "b" on the bottom sharing the end of the letter "h" slant to form the "b" inside of a slanted shaded square.

Status

2021-01-01 UTC
⟳ Refresh

LIVE APPLICATION Under Examination

Research	OneLook Acronym Finder
Serial Number	88464386
Mark Literal Elements	HB
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2019-12-03
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	Yes
Current Use	Yes
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Donna J. Bunton
Attorney Docket Number	DJB/51-771
Law Office Assigned	L20
Employee Name	RINKER, ANTHONY MICHAE

Timeline

IC 005. US 006 018 044 046 051 052. G & S: Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
IC 042. US 100 101. G & S: Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS. FIRST USE: 19950605. FIRST USE IN COMMERCE: 19950605